Pericles Calias

Pericles Calias

Corporate Officer/Principal presso SERNOVA BIOTHERAPEUTICS INC

Patrimonio netto: - $ in data 31/05/2026

Health Technology
Consumer Services
Commercial Services

Profilo

Pericles Calias currently works at Sernova Biotherapeutics, Inc., as Chief Development Officer & Head-R&D from 2025.
Dr. Calias also formerly worked at Genzyme Corp., as Scientist, Kiora Pharmaceuticals, Inc., as Vice President-Research & Development, Pharming Group NV, as Chief Scientific Officer from 2015 to 2016, Sucampo Pharmaceuticals LLC, as Vice President-Global CMC & Product Development from 2017 to 2018, The Charles Stark Draper Laboratory, Inc., as Principal, to-BBB Holding BV, as Chief Scientific Officer, to-BBB technologies BV, as Chief Scientific Officer, Avalo Therapeutics, Inc., as Chief Scientific Officer, Head-R&D from 2018 to 2020, and Revolo Biotherapeutics Ltd., as Chief Operating Officer.
Dr. Calias received his undergraduate degree from Suffolk University and doctorate degree from Tufts University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
24/02/2026 0 ( -.--% ) - $ 31/05/2026

Posizioni attive di Pericles Calias

SocietàPosizioneInizio
SERNOVA BIOTHERAPEUTICS INC Corporate Officer/Principal 10/03/2025

Precedenti posizioni note di Pericles Calias

SocietàPosizioneFine
AVALO THERAPEUTICS, INC. Direttore Tecnico/Scientifico/R&S 30/06/2020
SUCAMPO PHARMACEUTICALS, INC. Corporate Officer/Principal 01/05/2018
PHARMING GROUP N.V. Direttore Tecnico/Scientifico/R&S 01/01/2016
Direttore operativo -
Direttore Tecnico/Scientifico/R&S -
Vedi nel dettaglio l'esperienza di Pericles Calias

Formazione di Pericles Calias

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

24

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private12

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Pericles Calias
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA